Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is 0.92 as of 2026-10-06T15:07:30.571Z.
Calculation as of: 2026-10-06T15:07:30.571Z.
Quote observation: 2026-10-06T15:02:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c421eb3f9cbf80487861bd205397d7cf152d6c676755a2868786c2d5add3cf98
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
0.92
SECTOR MEDIAN · HEALTHCARE
2.36
median of 567 covered companies
CURRENT VS SECTOR MEDIAN
-61.02%
vs the sector median at left
Market Cap
$3.21M
PB Ratio
0.10
TTM Avg
320.85
3Y Avg
911.35
5Y Avg
666.87
Market Cap
$3.42M
PB Ratio
0.84
TTM Avg
4.65
3Y Avg
3.56
5Y Avg
3.55
Market Cap
$3.04M
PB Ratio
1.00
TTM Avg
3.01
3Y Avg
1.97
5Y Avg
1.58
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBody AI Ltd. (MBAI) | $3.17M | 0.92 | N/A | N/A | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.21M | 0.10 | 320.85 | 911.35 | 666.87 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | 0.84 | 4.65 | 3.56 | 3.55 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | 1.00 | 3.01 | 1.97 | 1.58 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.32M | 0.64 | 1.12 | 2.59 | 3.22 |
| IceCure Medical Ltd (ICCM)vs › | $3.33M | 0.28 | 4.39 | 5.59 | 5.08 |
| Eocene Ltd. (EOCN)vs › | $3.44M | N/A | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.40M | N/A | 7.82 | 4.46 | 9.07 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.95M | N/A | 2.51 | 1.61 | 1.61 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.46 | 0.83 | 232.76 | 141.77 |
P/B Ratio
0.92
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
